MedTrace Logo

Implications of Different Analgesic Models on Inflammatory Markers After Laparoscopic Cholecystectomy

NCT04609033 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2021-08-30

No results posted yet for this study

Summary

Postoperative abdominal and shoulder pain that are experienced in patients undergoing laparoscopic cholecystectomy (LC) is significant. Although it is generally less sever than post open cholecystectomy pain, it still causes an avoidable distress in the first 24 hours postoperatively

Conditions

  • Perioperative Pain

Interventions

DRUG

Bupivacaine

instillation of local anaesthetic in the abdominal cavity at the end of the procedure

DRUG

isotonic saline

instillation of local anaesthetic in the abdominal cavity at the end of the procedure

DRUG

Bupivacaine + morphine

instillation of local anaesthetic + morphine sulfate in the abdominal cavity at the end of the procedure

DRUG

Bupivacaine + morphine + ketamine

instillation of local anaesthetic + morphine sulfate + ketamine in the abdominal cavity at the end of the procedure

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-24
Primary Completion
2021-03-01
Completion
2021-03-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04609033 on ClinicalTrials.gov